PubMed

Comprehensive noninvasive arterial vascular evaluation.

Cohn JN, Duprez DA, Finkelstein SM.

Future Cardiol. 2009 Nov;5(6):573-9.PMID: 19886784 [PubMed - in process]Related articles

Definition and classification of hypertension: an update.

Giles TD, Materson BJ, Cohn JN, Kostis JB.

J Clin Hypertens (Greenwich). 2009 Nov;11(11):611-4.PMID: 19878368 [PubMed - in process]Related articles

Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.

Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.

Circulation. 2009 Oct 20;120(16):1577-84. Epub 2009 Oct 5.PMID: 19805651 [PubMed - indexed for MEDLINE]Related articles

President's Page: Beijing 2009.

Cohn JN.

Cardiovasc Drugs Ther. 2009 Sep 25. [Epub ahead of print] No abstract available. PMID: 19779815 [PubMed - as supplied by publisher]Related articles

Inotropic therapy for heart failure: paradise lost.

Cohn JN.

Eur Heart J. 2009 Sep 2. [Epub ahead of print] No abstract available. PMID: 19726435 [PubMed - as supplied by publisher]Related articles

Conflicts of interest: to eliminate them or manage them.

Cohn JN.

J Card Fail. 2009 Jun;15(5):375-6. No abstract available. PMID: 19477396 [PubMed - indexed for MEDLINE]Related articles

The president's page: target response or target dose.

Cohn JN.

Cardiovasc Drugs Ther. 2009 Aug;23(4):337. No abstract available. PMID: 19475501 [PubMed - indexed for MEDLINE]Related articles

Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.

McNamara DM, Tam SW, Sabolinski ML, Tobelmann P, Janosko K, Venkitachalam L, Ofili E, Yancy C, Feldman AM, Ghali JK, Taylor AL, Cohn JN, Worcel M.

J Card Fail. 2009 Apr;15(3):191-8. Epub 2008 Dec 23.PMID: 19327620 [PubMed - indexed for MEDLINE]Related articles

Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia.

Cohn JN, Wilson DJ, Neutel J, Houston M, Weinberger MH, Grimm R Jr, Smith DH, Sun W.

Am J Hypertens. 2009 Feb;22(2):137-44. Epub 2008 Dec 4.PMID: 19057518 [PubMed - indexed for MEDLINE]Related articles

Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure Trial.

Ghali JK, Tam SW, Sabolinski ML, Taylor AL, Lindenfeld J, Cohn JN, Worcel M.

J Card Fail. 2008 Nov;14(9):718-23. Epub 2008 Aug 9.PMID: 18995175 [PubMed - indexed for MEDLINE]Related articles

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).

Masson S, Latini R, Anand IS, Barlera S, Angelici L, Vago T, Tognoni G, Cohn JN; Val-HeFT Investigators.

J Am Coll Cardiol. 2008 Sep 16;52(12):997-1003.PMID: 18786480 [PubMed - indexed for MEDLINE]Related articles

Does the angiotensin receptor blocker telmisartan prevent morbid atherosclerotic events?

Cohn JN.

Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):526-7. Epub 2008 Jul 29.PMID: 18665135 [PubMed - indexed for MEDLINE]Related articles

Time to foster a rational approach to preventing cardiovascular morbid events.

Cohn JN, Duprez DA.

J Am Coll Cardiol. 2008 Jul 29;52(5):327-9.PMID: 18652938 [PubMed - indexed for MEDLINE]Related articles

Monitoring adherence to guidelines.

Cohn JN.

Circ Heart Fail. 2008 Jul;1(2):87-8. No abstract available. PMID: 19808277 [PubMed - indexed for MEDLINE]

Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.

Anand IS, Rector TS, Kuskowski M, Thomas S, Holwerda NJ, Cohn JN.

Circ Heart Fail. 2008 May;1(1):34-42.PMID: 19808268 [PubMed - indexed for MEDLINE]

Identifying early cardiovascular disease to target candidates for treatment.

Duprez DA, Cohn JN.

J Clin Hypertens (Greenwich). 2008 Mar;10(3):226-31. Review.PMID: 18326965 [PubMed - indexed for MEDLINE]Related articles

Arguments prove nothing unless verified. A commentary on Kaufman's "Epidemiologic analysis of racial/ethnic disparities: some fundamental issues and a cautionary example".

Exner DV, Cohn JN.

Soc Sci Med. 2008 Apr;66(8):1675-7. Epub 2008 Feb 11. No abstract available. PMID: 18267350 [PubMed - indexed for MEDLINE]Related articles

Establishing a new option for target-organ protection: rationale for ARB plus ACE inhibitor combination therapy.

Cohn JN, Goldman JM.

Am J Hypertens. 2008 Mar;21(3):248-56. Epub 2008 Jan 24. Review.PMID: 18219303 [PubMed - indexed for MEDLINE]Related articles

Reducing cardiovascular risk by blockade of the renin-angiotensin-aldosterone system.

Cohn JN.

Adv Ther. 2007 Nov-Dec;24(6):1290-304. Review.PMID: 18165212 [PubMed - indexed for MEDLINE]Related articles

Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.

Staszewsky L, Wong M, Masson S, Barlera S, Carretta E, Maggioni AP, Anand IS, Cohn JN, Tognoni G, Latini R; Valsartan Heart Failure Trial Investigators.

J Card Fail. 2007 Dec;13(10):797-804.PMID: 18068611 [PubMed - indexed for MEDLINE]Related articles

Review: increased waist circumference or waist-to-hip ratio is associated with increased risk of cardiovascular events.

Cohn JN.

Evid Based Med. 2007 Dec;12(6):184. No abstract available. PMID: 18063744 [PubMed]Related articles

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.

Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators.

Am J Cardiovasc Drugs. 2007;7(5):373-80.PMID: 18041162 [PubMed - indexed for MEDLINE]Related articles

Arterial stiffness as a risk factor for coronary atherosclerosis.

Duprez DA, Cohn JN.

Curr Atheroscler Rep. 2007 Aug;9(2):139-44. Review.PMID: 17877923 [PubMed - indexed for MEDLINE]Related articles

Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.

Tam SW, Sabolinski ML, Worcel M, Packer M, Cohn JN.

Clin Pharmacokinet. 2007;46(10):885-95.PMID: 17854237 [PubMed - indexed for MEDLINE]Related articles

Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities: the DETECTIV Pilot Study.

Duprez DA, Florea ND, Jones K, Cohn JN.

J Am Coll Cardiol. 2007 Aug 28;50(9):835-9. Epub 2007 Aug 13.PMID: 17719468 [PubMed - indexed for MEDLINE]Related articles

Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.

Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, Angelici L, Barlera S, Parrinello G, Maggioni AP, Tognoni G, Cohn JN; Val-HeFT Investigators.

Circulation. 2007 Sep 11;116(11):1242-9. Epub 2007 Aug 13.PMID: 17698733 [PubMed - indexed for MEDLINE]Related articlesFree article

Myocardial structural effects of aldosterone receptor antagonism in heart failure.

Cohn JN.

J Am Coll Cardiol. 2007 Aug 14;50(7):597-9. Epub 2007 Jul 30. No abstract available. PMID: 17692743 [PubMed - indexed for MEDLINE]Related articles

Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.

Cohn JN, Tam SW, Anand IS, Taylor AL, Sabolinski ML, Worcel M; A-HeFT Investigators.

J Card Fail. 2007 Jun;13(5):331-9.PMID: 17602978 [PubMed - indexed for MEDLINE]Related articles

Measuring endothelial dysfunction.

Duprez DA, Cohn JN.

J Hypertens. 2007 Jul;25(7):1513-4; author reply 1514-5. No abstract available. PMID: 17563578 [PubMed - indexed for MEDLINE]Related articles

Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.

Taylor AL, Ziesche S, Yancy CW, Carson P, Ferdinand K, Taylor M, Adams K, Olukotun AY, Ofili E, Tam SW, Sabolinski ML, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators.

Circulation. 2007 Apr 3;115(13):1747-53. Epub 2007 Mar 19.PMID: 17372175 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety in clinical trials.

Cohn JN.

J Am Coll Cardiol. 2007 Feb 13;49(6):729; author reply 729. Epub 2007 Jan 26. No abstract available. PMID: 17291941 [PubMed - indexed for MEDLINE]Related articles

Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.

Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, Archambault WT, Adams KF, Olukotun AY, Worcel M, Cohn JN.

J Am Coll Cardiol. 2007 Jan 2;49(1):32-9. Epub 2006 Dec 14.PMID: 17207719 [PubMed - indexed for MEDLINE]Related articles

Rationale for angiotensin II receptor blocker therapy in chronic heart failure.

Cohn JN.

J Renin Angiotensin Aldosterone Syst. 2000 Jun;1(2 Suppl):S38-40.PMID: 17199220 [PubMed - in process]Related articles

Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial.

Cicoira M, Maggioni AP, Latini R, Barlera S, Carretta E, Janosi A, Soler Soler J, Anand I, Cohn JN; Val-HeFT Investigators.

Eur J Heart Fail. 2007 Apr;9(4):397-402. Epub 2006 Dec 12.PMID: 17166768 [PubMed - indexed for MEDLINE]Related articles

Outcomes by gender in the African-American Heart Failure Trial.

Taylor AL, Lindenfeld J, Ziesche S, Walsh MN, Mitchell JE, Adams K, Tam SW, Ofili E, Sabolinski ML, Worcel M, Cohn JN; A-HeFT Investigators.

J Am Coll Cardiol. 2006 Dec 5;48(11):2263-7. Epub 2006 Nov 9.PMID: 17161257 [PubMed - indexed for MEDLINE]Related articles

The use of race and ethnicity in medicine: lessons from the African-American Heart Failure Trial.

Cohn JN.

J Law Med Ethics. 2006 Fall;34(3):552-4, 480.PMID: 17144178 [PubMed - indexed for MEDLINE]Related articles

What is the role of angiotensin-receptor blockade in cardiovascular protection?

Cohn JN.

Am Heart J. 2006 Nov;152(5):859.e1-8.PMID: 17070145 [PubMed - indexed for MEDLINE]Related articles

Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.

McNamara DM, Tam SW, Sabolinski ML, Tobelmann P, Janosko K, Taylor AL, Cohn JN, Feldman AM, Worcel M.

J Am Coll Cardiol. 2006 Sep 19;48(6):1277-82. Epub 2006 Aug 14.PMID: 16979018 [PubMed - indexed for MEDLINE]Related articles

Monitoring vascular health beyond blood pressure.

Duprez DA, Cohn JN.

Curr Hypertens Rep. 2006 Aug;8(4):287-91. Review.PMID: 16884658 [PubMed - indexed for MEDLINE]Related articles

Measuring endothelial function.

Lockhart CJ, McVeigh GE, Cohn JN.

Curr Diab Rep. 2006 Aug;6(4):267-73. Review.PMID: 16879777 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety in clinical trials in cardiovascular disease.

Cohn JN.

J Am Coll Cardiol. 2006 Aug 1;48(3):430-3. Epub 2006 Jul 12. Review.PMID: 16875964 [PubMed - indexed for MEDLINE]Related articles

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN; Val-HeFT Investigators.

Clin Chem. 2006 Aug;52(8):1528-38. Epub 2006 Jun 15.PMID: 16777915 [PubMed - indexed for MEDLINE]Related articlesFree article

The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).

Masson S, Latini R, Anand IS, Barlera S, Judd D, Salio M, Perticone F, Perini G, Tognoni G, Cohn JN; Val-HeFT investigators.

J Card Fail. 2006 Jun;12(5):375-80.PMID: 16762801 [PubMed - indexed for MEDLINE]Related articles

Prognosis and mechanism of death in treated heart failure: data from the placebo arm of Val-HeFT.

Cohn JN, Carson PE, O'Connor C, Opasich C, Piña IL, Scherillo M, Sinagra G, Warner-Stevenson L, Tristani FE, Volpi A.

Congest Heart Fail. 2006 May-Jun;12(3):127-31.PMID: 16760697 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology.

Cohn JN, Colucci W.

Am J Cardiol. 2006 May 22;97(10A):4F-12F. Epub 2006 Apr 5. Review.PMID: 16698330 [PubMed - indexed for MEDLINE]Related articles

B-type natriuretic peptide and artery stiffness.

Cohn JN.

Am J Hypertens. 2006 May;19(5):437-8. No abstract available. PMID: 16647609 [PubMed - indexed for MEDLINE]Related articles

B-type natriuretic peptide level had reduced specificity for diagnosing heart failure in dyspnea with atrial fibrillation in the emergency department.

Cohn JN.

ACP J Club. 2006 Mar-Apr;144(2):48. No abstract available. PMID: 16539363 [PubMed]Related articles

Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life.

Rector TS, Anand IS, Cohn JN.

J Card Fail. 2006 Mar;12(2):87-92.PMID: 16520254 [PubMed - indexed for MEDLINE]Related articles

Arterial stiffness, vascular disease, and risk of cardiovascular events.

Cohn JN.

Circulation. 2006 Feb 7;113(5):601-3. No abstract available. PMID: 16461830 [PubMed - indexed for MEDLINE]Related articlesFree article

Incremental prognostic value of changes in B-type natriuretic peptide in heart failure.

Latini R, Masson S, Wong M, Barlera S, Carretta E, Staszewsky L, Vago T, Maggioni AP, Anand IS, Tan LB, Tognoni G, Cohn JN; Val-HeFT Investigators.

Am J Med. 2006 Jan;119(1):70.e23-30.PMID: 16431191 [PubMed - indexed for MEDLINE]Related articles